Gain Therapeutics (GANX) - News Mentions

Sign up to add (GANX) to your portfolio and access more historical data.

00%
Est. daily news mentions.

Sign up to access historical data

Sign up

Similar companies

Company News Mentions
Amgen
Amgen
AMGN		 1 0%
Gilead Sciences
Gilead Sciences
GILD		 0 100%
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals
CPRX		 0 0%
Inovio Pharmaceuticals
Inovio Pharmaceuticals
INO		 1 0%
Anavex Life Sciences
Anavex Life Sciences
AVXL		 0 0%
Gain Therapeutics Reports Financial Results for Third Quarter 2024 and Provides Corporate Update
November 14
Gain Therapeutics : Reports Financial Results for Third Quarter 2024 and Provides Corporate Update Form 8 K
November 14
Head-To-Head Analysis: Gain Therapeutics (NASDAQ:GANX) and GSK (NYSE:GSK)
November 10
Short Interest in Gain Therapeutics, Inc. (NASDAQ:GANX) Decreases By 12.6%
October 29
Gain Therapeutics Regains Compliance with Nasdaq Listing Requirements
October 22
Gain Therapeutics Presents Data at 36ᵗʰ EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics Demonstrating Identification of Allosteric Inhibitors Targeting DDR2
October 22
Gain Therapeutics presents data at 36th ENA symposium
October 22
Gain Therapeutics Announces Poster Presentation at 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
October 14
Gain Therapeutics (NASDAQ:GANX) Given Buy Rating at HC Wainwright
October 10
Gain Therapeutics Announces Positive Preclinical Data for GT-02287
October 10
Stock Analysts’ Updated EPS Estimates for October 9th (AAPL, AAV, ALAB, ARHS, BAC, BDTX, BEP, BKD, DQ, GANX)
October 9
Gain Therapeutics to Present at Michael J. Fox Foundation’s 16th Annual Parkinson’s Disease Therapeutics Conference
October 8
Gain Therapeutics to present at MJFF's Annual Parkinson's Disease Conference
October 8
Gain Therapeutics : Presents Preclinical GT 02287 Data at Neuroscience 2024 Form 8 K
October 8
Gain Therapeutics Excels in Neurodegenerative Drug Trials
October 7
Gain Therapeutics Presents Preclinical GT-02287 Data at Neuroscience 2024
October 7

How often is Gain Therapeutics mentioned in the news?

Gain Therapeutics was mentioned an estimated 0 times in online prominent news articles yesterday.

Analyzing News Mentions, how is Gain Therapeutics performing compared to its industry peers?

Gain Therapeutics underperforms its industry peers when it comes to News Mentions, ranking dead last.

Has there been an increase or decrease in news mentions of Gain Therapeutics in the last month?

There has been no significant change in the number of news mentions for Gain Therapeutics' compared to the last month.

Why is it important to track news mentions for Gain Therapeutics?

By monitoring mentions in the news for Gain Therapeutics, investors stay up to date on impactful events for the company, its industry and its competitors. Positive news might affect price in a positive way and negative news might affect price in a negative way. By tracking mentions over time, investors can also identify patterns, explore popularity and make informed decisions based on the evolving perception of Gain Therapeutics, ultimately improving their investment strategies.

Sign up and get more insights on Gain Therapeutics.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.

Top Stocks

Trending Stocks
Trending Stocks on WallStreetBets
Trending Stocks on Reddit
Top Stocks
Top Stock Performers Today
Bottom Stock Performers Today
Best Airlines Stocks
Best Bank Stocks
Best Semiconductor Stocks
Best Energy Stocks
Best Fintech Stocks
Best Robotics Stocks
Best Insurance Stocks

Our Data

Datasets
Stock alerts
AI Stock Picks
AI Stock Picks - Results
Fear & Greed Index
Meme Stocks
Threads Users
Stock Predictor
Stock Picking Reviews
Stock Trading Signals
House & Congress Trading
Earnings Calendar
Index

AltIndex

News
Pricing
Sign up
Log in
API
Journalist Access
Data Disclaimer
Contact